Clareo Health | A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kaleido Biosciences
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Be male or female, ≥18 years of age
Be willing and able to give informed consent
Screening/Randomization telemedicine visit within 2 days of testing positive test for COVID-19
Having self-reported fever or cough for not more than 72 hours prior to COVID-19 testing
Mild to moderate COVID-19
Able to adhere to the study visit schedule and other protocol requirements.
You may not be if
Patients who are hospitalized for in-patient treatment or currently being evaluated for potential hospitalization at the time of informed consent for conditions other than COVID- 19
